Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- 21 January 2026
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 40 (2) , 129-144
Abstract
Alopecia is a multifactorial condition resulting from the convergence of systemic pathologies, pharmacologic exposures, genetic predispositions, and environmental factors. Among these, systemic diseases and medications play a prominent role by initiating biological cascades that disrupt follicular integrity. Systemic diseases and medications disrupt follicular homeostasis via mechanisms such as inflammation, oxidative stress, hormonal imbalance, and immune dysregulation. Endocrine disorders, metabolic syndromes, and nutritional deficiencies impair follicular function, while chemotherapeutics, antifungals, anticoagulants, and hormonal agents further compromise follicular cycling and stem cell viability. Understanding these mechanistic pathways is essential for predicting and mitigating drug-associated alopecia and informing targeted interventions. Precision medicine approaches that address systemic drivers while optimizing pharmacologic regimens are critical to preserving follicular integrity. Current treatments like minoxidil, platelet-rich plasma, and surgical restoration provide symptomatic relief but often fail to achieve lasting results. In contrast, emerging molecular therapies, including bioengineered exosomes, stem cell applications, and peptide-based formulations that target key signalling pathways and growth factors, hold promise for more regenerative and sustained hair restoration outcomes. Given the condition’s complexity, a multidisciplinary framework integrating dermatology, endocrinology, immunology, and pharmacology is essential. Cross-specialty collaboration will be pivotal for advancing individualised, mechanism-driven care. Ultimately, accurate etiologic diagnosis remains the cornerstone of effective, tailored treatment strategies.Keywords
This publication has 157 references indexed in Scilit:
- Hair Loss Induced by Lopinavir‐RitonavirPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Tacrolimus-Induced Alopecia in Female Kidney-Pancreas Transplant RecipientsTransplantation, 2005
- The psychological impact of alopeciaBMJ, 2005
- Notch1 is essential for postnatal hair follicle development and homeostasisDevelopmental Biology, 2005
- BMP signaling in the control of skin development and hair follicle growthDifferentiation, 2004
- Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicleThe EMBO Journal, 2000
- Indinavir use: associated reversible hair loss and mood disturbanceInternational Journal of STD & AIDS, 2000
- Procyanidin Oligomers Selectively and Intensively Promote Proliferation of Mouse Hair Epithelial Cells In Vitro and Activate Hair Follicle Growth In Vivo11The authors disclosed conflict of interest.Journal of Investigative Dermatology, 1999
- Alopecia Associated With Zidovudine TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
- Drug-Induced Hair Loss and Hair GrowthDrug Safety, 1994